3,0
18 juin 2008
Employé (ancien)
Nutley, NJ
Recommande
Approbation du PDG
Perspective commerciale
Avantages
Large company with plenty of funds available for investment or acquisition. Drugs will receive national and international attention - even if that attention is primarily negative in recent years.
Inconvénients
Senior management (NAOC) has very little idea of how to actually run a successful sales organization. They get bogged down in the task-oriented society where everyone at Nutley is busy CYA. I can't believe more heads didn't roll after the horrid way they handled Cera in the United States. Plan B? No, we don't need a Plan B. If Actemra hits a few snags (and why wouldn't it?) plan on Roche NA being significantly smaller in 2010 than it was in 2007.